Stock listing
Bonus Biogroup Ltd.
Selected listing: BONS · NASDAQ · USD · US
Bonus Biogroup Ltd. (NASDAQ:BONS), Health Technology. Latest release Jul 14, 2025: Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M.…
- Ticker
- NASDAQ:BONS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Bonus Biogroup Ltd.
The company focuses on innovative biotechnological solutions. It is actively engaged in the development and commercialization of its products within the biotechnology sector.
Latest news from Bonus Biogroup Ltd.
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
July 14, 2025
Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress
February 20, 2025